SYMBIOTIC.BLUE LTD

Drug Discovery

  • Funding stage: Pre-seed
  • Technology type: Tech Bio
  • Western Central London
Phone
+447462070088
Membership category
Emerging Y1

Np-105 Icentre, Howard Way, Newport Pagnell, Buckinghamshire, MK16 9PY, United Kingdom

SYMBIOTIC.BLUE LTD at a glance

Where Neuroscience Meets AI to Redefine Drug Discovery

About SYMBIOTIC.BLUE LTD

Symbiotic.blue, a newly launched UK techbio venture, is developing a next-generation artificial intelligence-driven drug discovery (AIDD) platform. By enhancing generative AI with neuroscience-inspired methodologies, the company aims to develop smarter, multi-targeted therapeutics to address complex diseases, starting with obesity.

Founded by a team of seasoned life sciences entrepreneurs and world-renowned academics from the Universities of Oxford and Cambridge, Symbiotic.blue is currently raising a pre-seed round to build its proprietary platform and initiate early-stage discovery programs

Therapeutic area(s)